Neuroscience Research Center, LLC

Canton, Ohio 44718

2 studies enrolling now · 17 studies all time

What they study most

Alzheimer Disease, Alzheimer's Disease Dementia, Early Alzheimer's Disease, Early Alzheimer´s Disease, Episodic Migraine, Excessive Daytime Sleepiness, Focal Epilepsy, Idiopathic Hypersomnia, Migraine, Mild Cognitive Impairment Due to Alzheimer's Disease, OSA, Obsessive Compulsive Disorder

Studies at this site

• A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease — Recruiting now
• A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE) — Completed
• A Study to Learn About the Safety of Diranersen (BIIB080) Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age — Running, not enrolling
• A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus) — Completed
• A Trial of Eptinezumab in Participants With Migraine and Insufficient Response to Anti-CGRP Medications — Running, not enrolling
• A Study of NE3107 in Early Parkinson's — Running, not enrolling
• Long-term Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive Disorder — Stopped early
• A Long-Term Safety and Effectiveness Study to Evaluate Pitolisant in Adult Patients With Idiopathic Hypersomnia — Completed
• Parallel Arm Trial of AD109 and Placebo With Patients With OSA (LunAIRo) — Completed
• Phase 3, Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of AR1001 in Participants With Early Alzheimer's Disease (Polaris-AD) — Running, not enrolling
• Safety and Efficacy of TRx0237 in Subjects With Alzheimer's Disease Followed by Open-Label Treatment — Completed
• Simufilam 100 mg for Mild-to-Moderate Alzheimer's Disease — Completed
• Open-label Extension for Phase 3 Clinical Trials of Simufilam — Stopped early
• Continuation Protocol for Obstructive Sleep Apnea (OSA) — Enrolling by invitation
• A Phase 3 Study to Assess the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia — Completed
• A Study of Galcanezumab (LY2951742) in Adult Participants With Episodic Migraine — Completed
• ENACT: A Study of ENX-101 as Adjunctive Treatment in Patients With Focal Seizures — Withdrawn before enrolling